tiprankstipranks
Trending News
More News >

Quadrise Signs Agreement for Marine Fuel Trials with MAC2

Story Highlights
  • Quadrise has partnered with MAC2 to produce MSAR® and bioMSAR™ fuels for marine trials.
  • The agreement may lead to permanent commercial supply operations in the marine sector.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Quadrise Signs Agreement for Marine Fuel Trials with MAC2

Quadrise Fuels International ( (GB:QED) ) has provided an update.

Quadrise Plc has signed a Services Supply Agreement with MAC2 Solutions NV to produce MSAR® and bioMSAR™ fuels for marine vessel trials on the MSC Leandra V, set to begin in Q2 2025. The agreement outlines the responsibilities of both parties, with Quadrise providing technology and fuel production equipment, and MAC2 offering support services. The trials aim to secure a letter of no objection from Wärtsilä and will potentially lead to permanent commercial supply operations in the marine sector through the Port of Antwerp-Bruges.

More about Quadrise Fuels International

Quadrise is a provider of MSAR® and bioMSAR™ emulsion technology, fuels, and biofuels, offering innovative solutions to reduce energy costs and greenhouse gas emissions for clients in the global power generation, shipping, industrial, and refining industries.

YTD Price Performance: -42.04%

Average Trading Volume: 9,817,844

Technical Sentiment Signal: Sell

Current Market Cap: £82.27M

For an in-depth examination of QED stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App